Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

被引:24
|
作者
Verselis, SJ
Rheinwald, JG
Fraumeni, JF
Li, FP [1 ]
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Skin Dis Res Ctr, Boston, MA 02115 USA
[5] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
关键词
p53; germline mutation; Li-Fraumeni syndrome; alternate splicing;
D O I
10.1038/sj.onc.1203758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Germline mutations in the p53 tumor suppressor gene predispose to a variety of cancers in families with Li-Fraumeni syndrome. Most germline p53 mutations observed to date cause amino acid substitutions in the protein's central sequence-specific DNA binding domain. Outside this conserved core region, however, we found novel alterations in sequences that regulate precursor mRNA splicing in three Li-Fraumeni syndrome families. Two splice site mutations affected the consensus sequence at the splice donor sites of introns 1 and 9, and produced unstable variant transcripts in normal cells. A third mutation at the splice acceptor site of intron 9 generated splicing at a cryptic acceptor site in intron 9, These splice site alterations emphasize the need to examine both noncoding and untranslated regions of the p53 gene for germline mutations in Li-Fraumeni syndrome families.
引用
收藏
页码:4230 / 4235
页数:6
相关论文
共 50 条
  • [1] Novel p53 splice site mutations in three families with Li-Fraumeni syndrome
    Sigitas J Verselis
    James G Rheinwald
    Joseph F Fraumeni
    Frederick P Li
    Oncogene, 2000, 19 : 4230 - 4235
  • [2] P53 MUTATIONS IN FAMILIES WITH THE LI-FRAUMENI FAMILY CANCER SYNDROME
    SANTIBANEZKOREF, M
    BIRCH, JM
    HARTLEY, AL
    JONES, PHM
    CRAFT, AW
    EDEN, OB
    CROWTHER, D
    KELSEY, AM
    HARRIS, M
    BLAIR, V
    MITCHELL, EL
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2107 - 2107
  • [3] P53 GERMLINE MUTATIONS IN LI-FRAUMENI SYNDROME
    SANTIBANEZKOREF, MF
    BIRCH, JM
    HARTLEY, AL
    JONES, PHM
    CRAFT, AW
    EDEN, T
    CROWTHER, D
    KELSEY, AM
    HARRIS, M
    LANCET, 1991, 338 (8781): : 1490 - 1491
  • [4] LI-FRAUMENI SYNDROME AND P53 GERMLINE MUTATIONS
    LEBLANC, T
    SOUSSI, T
    ARCHIVES DE PEDIATRIE, 1994, 1 (01): : 61 - 70
  • [5] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 197 - 213
  • [6] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 83 - 92
  • [7] Beyond Li-Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations
    Gonzalez, K. D.
    Noltner, K. A.
    Buzin, C. H.
    Gu, D.
    Wen-Fong, C. Y.
    Ngyuen, V. Q.
    Han, J. H.
    Lowstuter, K.
    Longmate, J.
    Sommer, S. S.
    Weitzel, J. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] GERM-LINE P53 MUTATIONS IN 15 FAMILIES WITH LI-FRAUMENI SYNDROME
    FREBOURG, T
    BARBIER, N
    YAN, YX
    GARBER, JE
    DREYFUS, M
    FRAUMENI, J
    LI, FP
    FRIEND, SH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 56 (03) : 608 - 615
  • [9] Li-Fraumeni syndrome: p53 and beyond
    Wasserman, Jonathan
    Villani, Anita
    Samuel, Nardin
    Merino, Diana
    Novokmet, Ana
    Pienkowska, Margaret
    IdSaid, Badr
    Malkin, David
    CANCER RESEARCH, 2014, 74 (23)
  • [10] Novel p53 germline mutation in a patient with Li-Fraumeni syndrome
    Wong, SS
    Lozano, G
    Gaff, CL
    Gardner, RJM
    Strong, LC
    Aittomäki, K
    Lindeman, GJ
    INTERNAL MEDICINE JOURNAL, 2003, 33 (12) : 621 - U8